Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Nov;12(11):641-50.
doi: 10.1038/nrurol.2015.238. Epub 2015 Oct 13.

The practical management of testosterone deficiency in men

Affiliations
Review

The practical management of testosterone deficiency in men

Antonio Aversa et al. Nat Rev Urol. 2015 Nov.

Abstract

Despite increased global interest in testosterone deficiency in men and its treatment with testosterone therapy, practical aspects of care remain confusing to many practitioners. Testosterone deficiency can result from testicular dysfunction (primary hypogonadism) or hypothalamic-pituitary dysfunction (secondary hypogonadism), and be congenital or acquired. Sexual and nonsexual symptoms of testosterone deficiency can negatively affect quality of life and cause considerable general health concerns. Investigation of testosterone deficiency should be undertaken in men with symptoms of reduced libido, erectile dysfunction, depression, fatigue, poor concentration, and poor memory. Total and free testosterone are the most frequently used tests and evaluating serum concentrations of luteinizing hormone aids determination of primary versus secondary testosterone deficiency. Multiple formulations of testosterone therapy are available, but symptomatic benefits might not manifest for several weeks to many months; long-acting formulations are convenient and improve compliance. Concerns regarding cardiovascular and prostate cancer risks are not supported by current evidence, monitoring during therapy is mandatory. On balance, testosterone therapy can be considered a safe and effective treatment for testosterone deficiency.

PubMed Disclaimer

References

    1. Drugs. 2012 Aug 20;72(12):1591-603 - PubMed
    1. J Endocrinol Invest. 2014 Apr;37(4):401-11 - PubMed
    1. J Clin Endocrinol Metab. 2004 Nov;89(11):5429-34 - PubMed
    1. Curr Opin Endocrinol Diabetes Obes. 2010 Jun;17(3):269-76 - PubMed
    1. Int J Clin Pract. 2014 Mar;68(3):314-29 - PubMed

LinkOut - more resources